# The HANAROSTENT® Multi-Hole™ Biliary Stent is Indicated for Use in the Palliative Treatment of Biliary Strictures Produced by Malignant Neoplasms and the Study is to Demonstrate Clinical Safety and Performance of the Multi-Hole™ Stent for the Palliative Treatment of Malignant Biliary Obstruction.

> **NCT07715240** · NA · NOT_YET_RECRUITING · sponsor: **Olympus Corporation of the Americas** · enrollment: 66 (estimated)

## Conditions studied

- Biliary Strictures Caused by Malignant Neoplasms

## Interventions

- **DEVICE:** Biliary Stent for the Palliative Treatment of Malignant Biliary Obstruction

## Key facts

- **NCT ID:** NCT07715240
- **Lead sponsor:** Olympus Corporation of the Americas
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-31
- **Primary completion:** 2027-02-27
- **Final completion:** 2028-05-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-07-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715240, "The HANAROSTENT® Multi-Hole™ Biliary Stent is Indicated for Use in the Palliative Treatment of Biliary Strictures Produced by Malignant Neoplasms and the Study is to Demonstrate Clinical Safety and Performance of the Multi-Hole™ Stent for the Palliative Treatment of Malignant Biliary Obstruction.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07715240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*